Patents Assigned to Blanchette Rockefeller Neursociences Institute
  • Publication number: 20050059092
    Abstract: A method of diagnosing Alzheimer's disease in a patient comprises determining whether the phosphorylation level of an indicator protein in cells of the patient after stimulus with an activator compound is abnormally elevated as compared to a basal phosphorylation level, the indicator protein being e.g. Erk1/2 and the activator compound being e.g. bradykinin.
    Type: Application
    Filed: February 27, 2002
    Publication date: March 17, 2005
    Applicant: Blanchette Rockefeller Neursociences Institute
    Inventors: Wei-Qin Zhao, Daniel Alkon